Paper413795
Experimental evaluation of HR756, a new cephalosporin derivative: pre-clinical study.
Heymès R and 2 others. Infection, 1977. Cited by 72 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Experimental evaluation of HR756, a new cephalosporin derivative: pre-clinical study. Papers, record 413795. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/413795
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cephalosporins | Major topic |
| Animals | |
| Dogs | |
| Enterobacteriaceae | |
| Klebsiella Infections | |
| Mice | |
| Microbial Sensitivity Tests | |
| Pseudomonas aeruginosa | |
| Pyelonephritis | |
| Rats | |
| Staphylococcal Infections | |
| Streptococcal Infections |
Source PubMed
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 72 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 10,319,137 | Synthesis and antibacterial activity of new cephalosporins with lactonyloxyimino moiety. | Arch Pharm Res | 1994 | https://conductscience.org/library/papers/10319137 | PubMed |
| 7,843,824 | The antimicrobial activity of cefotaxime: comparative multinational hospital isolate surveys covering 15 years. | Infection | 1994 | https://conductscience.org/library/papers/7843824 | PubMed |
| 7,247,361 | Activity of a new cephalosporin antibiotic, Ro 13-9904 against dense populations of selected enterobacteria. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/7247361 | PubMed |
| 6,994,642 | GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6994642 | PubMed |
| 6,972,728 | Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6972728 | PubMed |
| 6,972,194 | Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6972194 | PubMed |
| 6,601,470 | In vitro antibacterial activity of SM-1652, a new broad-spectrum cephalosporin with antipseudomonal activity. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6601470 | PubMed |
| 6,293,977 | Comparative beta-lactamase hydrolysis of and inhibition by 7-aminothiazolyl alpha-methoxyimino cephalosporins. | Infection | 1982 | https://conductscience.org/library/papers/6293977 | PubMed |
| 6,289,734 | Ceftriaxone: in vitro studies and clinical evaluation. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6289734 | PubMed |
| 6,252,829 | Comparative in vitro activities of cefotaxime and ceftizoxime (FK749): new cephalosporins with exceptional potency. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6252829 | PubMed |
| 6,250,981 | Cefotaxime pharmacokinetics following a single intravenous dose to patients with varying renal function. | Infection | 1980 | https://conductscience.org/library/papers/6250981 | PubMed |
| 6,247,965 | Biosynthesis of peptidoglycan in Pseudomonas aeruginosa: comparison of the inhibitory effects of cefotaxime, its anti isomer, and the syn S-oxide compound. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6247965 | PubMed |
| 6,212,596 | Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits. | J Clin Microbiol | 1982 | https://conductscience.org/library/papers/6212596 | PubMed |
| 6,188,701 | Cefotaxime concentrations in prostatic tissue. | Infection | 1983 | https://conductscience.org/library/papers/6188701 | PubMed |
| 6,092,278 | Chemotherapeutic properties of the new cephalosporin antibiotic HR810 in laboratory animals. | Infection | 1984 | https://conductscience.org/library/papers/6092278 | PubMed |
| 2,504,597 | In vitro antibacterial properties of cefetamet and in vivo activity of its orally absorbable ester derivative, cefetamet pivoxil. | Eur J Clin Microbiol Infect Dis | 1989 | https://conductscience.org/library/papers/2504597 | PubMed |
| 526,000 | Pharmacokinetics of cefotaxime. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/526000 | PubMed |
| 525,994 | Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activities. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/525994 | PubMed |
| 485,125 | Human pharmacology of cefotaxime (HR 756), a new cephalosporin. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/485125 | PubMed |
| 478,651 | The sensitivity of gentamicin-resistant gram-negative bacilli to cefotaxime, other cephalosporins and aminoglycosides. | Infection | 1979 | https://conductscience.org/library/papers/478651 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/413795
GET https://conductscience.org/api/papers/v1/413795/cited_by?page=2